Coloplast A/S (CLPBF)

Market Cap	29.35B
Revenue (ttm)	3.78B
Net Income (ttm)	713.63M
Shares Out	n/a
EPS (ttm)	3.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	138.00
Previous Close	138.00
Day's Range	124.57 - 138.00
52-Week Range	99.78 - 143.15
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1954
• Employees: 15,692
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLPBF

Financial Performance

In 2023, Coloplast's revenue was 24.50 billion, an increase of 8.51% compared to the previous year's 22.58 billion. Earnings were 4.78 billion, an increase of 1.64%.

Financial numbers in DKK